Replies to post #224 on AssAssertio Holdings Inc (ASRT)

[KRISGO]

I'm referring to the same-day dosing of Rovedon. The full abstract from ASRT has been leaked on San Antonio Breast Cancer Conference website, which is definitely positive news. It has the potential to boost sales and is gaining attention, but the stock doesn't seem to be moving upward. Any thoughts on why that is?

[Grundle]

So no chance of Rolvedon '24 (and 25) sales being more than 175m to pay out the CVR from Spectrum?